RT Journal Article
T1 A review of international medical device regulations: Contact lenses and lens care solutions
A1 Zaki, Marina
A1 Pardo, Jesús
A1 Carracedo Rodríguez, Juan Gonzalo
AB Medical devices are under strict regulatory oversight worldwide and such regulations prioritise patient safety and efficacy over anything else. Contact lenses fall under the medical device category - a result of direct contact with the eye. Equally regulated are the contact lens care product solutions, which include cleaning and maintenance solutions and lubricating and rewetting drops. In the USA, it is the FDA Centre for Devices and Radiological Health (CDRH) overseeing the regulations of medical devices, since 1976. In the European Union, it is the EU Commission responsible for regulating devices in Member States. The categorisation of contact lenses into medical devices is based on their inherent risk to the wearer. Contact lenses are subject to crucial regulatory oversight from concept to clinical evaluation, clinical investigations through to the finished lens product, and finally, strict conditions associated with their marketing approval including post-marketing surveillance. The physiochemical and manufacturing testing, such as biocompatibility testing alongside pre-clinical stability, sterility and microbiological testing are just some of the essential testing lenses must endure. Only through understanding the inherent risks and potential complications that can arise from contact lens wear, can one truly appreciate the need to adhere to strict regulations. The challenge however, lies in the need for more standardised regulations and flexible approaches, ensuring innovative device technologies reach patients in a timely manner without compromising public health and safety. This review highlights some key requirement, differences and similarities between the FDA and EU administrations in the approval of contact lenses.
PB Elsevier
SN 1367-0484
YR 2018
FD 2018-11-14
LK https://hdl.handle.net/20.500.14352/13101
UL https://hdl.handle.net/20.500.14352/13101
LA eng
NO Received 29 May 2018, Revised 2 November 2018, Accepted 2 November 2018, Available online 14 November 2018.
NO Unión Europea. H2020
DS Docta Complutense
RD 29 abr 2024